AL amyloidosis diagnosed using anti-IGLL5 antibody: a case report

Takayuki HiroiDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan; Correspondence[email protected]

Toshiki MushinoDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Ken TanakaDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Yoshiaki FuruyaDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Yoshikazu HoriDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Takehiro OiwaDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Hiroshi KobataDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Yusuke YamashitaDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Hiroki HosoiDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Shogo MurataDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Akinori NishikawaDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Shinobu TamuraDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Suguru TakeuchiJapanese Red Cross Wakayama Medical Center, Wakayama, Japan;

Masaharu NohgawaJapanese Red Cross Wakayama Medical Center, Wakayama, Japan;

Taro YamashitaDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;

Yukio AndoDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;

Hiroyuki HataDivision of Informative Clinical Sciences, Faculty of Medical Sciences, Kumamoto University, Kumamoto, Japan

Takashi SonokiDepartment of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan;

Reference